Home › Therapeutic areas › Respiratory › Progressive Pulmonary Fibrosis

Progressive Pulmonary Fibrosis (2 companies)

Companies with an active program in Progressive Pulmonary Fibrosis.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
INSM Insmed CardiovascularImmunology+3 Rare 2 Approved $26.7B 15
LQDA Liquidia CardiovascularImmunology+1 Rare 1 Approved $5.11B 9